The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage

European Journal of Pharmacology

Volumn 532, Issue 1-2, 2006, Pages 138-144

  Getting, Stephen J ^a   Di Filippo, Clara ^b   D'Amico, Michele ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Chemokine; Cytokine; Inflammation; Melanocortin; Myocardial ischaemia

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; CHEMOKINE; CYTOKINE; HP 228; PEPTIDE HORMONE; UNCLASSIFIED DRUG; URATE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE MIGRATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PERITONITIS; PRIORITY JOURNAL; REPERFUSION;

ACUTE DISEASE; ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; CARRAGEENAN; CHEMOKINES; CHEMOKINES, CXC; CYCLIC AMP; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; INFLAMMATION; INTERLEUKIN-1; MACROPHAGES, PERITONEAL; MALE; MICE; MYOCARDIAL REPERFUSION INJURY; OLIGOPEPTIDES; PERITONITIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID; ZYMOSAN;

EID: 33644500196     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.023     Document Type: Article

References (40)

1. G. Abou-Mohamed, A. Papapetropoulos, D. Ulrich, J.D. Catravas, R.R. Tuttle, and R.W. Caldwell HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro J. Pharmacol. Exp. Ther. 275 1995 584 591
2. S. Adachi, T. Nakano, H. Vliagoftis, and D.D. Metcalfe Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone J. Immunol. 163 1999 3363 3368
3. S. Adachi, E. Morii, D. Kim, H. Ogihara, T. Jippo, A. Ito, Y.M. Lee, and Y. Kitamura Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice J. Immunol. 164 2000 855 860
4. M.N. Ajuebor, A.M. Das, L. Virag, R.J. Flower, C. Szabo, and M.P. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10 J. Immunol. 162 1999 1685 1691
5. D. Berry, and B. Lindgren Statistics: Theory and methods 1990
6. A. Blum Interleukin-1 in acute myocardial infarction Lancet 347 1996 56
7. N.A. Calcutt, K.C. Dines, and R.M. Cesena Effects of the peptide HP228 on nerve disorders in diabetic rats Metabolism 47 1998 650 656
8. A. Catania, S. Gatti, G. Colombo, and J.M. Lipton Targeting melanocortin receptors as a novel strategy to control inflammation Pharmacol. Rev. 56 2004 1 29
9. G. Ceriani, J. Diaz, S. Murphree, A. Catania, and J.M. Lipton The neuropeptide alpha-melanocyte stimulating hormone inhibits experimental arthritis in rats Neuroimmunomodulation 1 1994 28 32
10. A.M. Das, R.J. Flower, and M. Perretti Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo J. Leukoc. Biol. 64 1998 156 162
11. R. Delgrado, A. Carlin, L. Airaghi, M.T. Demitri, L. Meda, D. Galimberti, P. Baron, J.M. Lipton, and A. Catania Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia J. Leukoc. Biol. 63 1998 740 745
12. W. Fan, B.A. Boston, R.A. Kesterson, V.J. Hruby, and R.D. Cone Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385 1997 165 168
13. I. Gantz, Y. Konda, T. Tashiro, Y. Shimoto, H. Miwa, G. Munzert, S.J. Watson, J. DelValle, and T. Yamada Molecular cloning of a novel melanocortin receptor J. Biol. Chem. 268 1993 8246 8250
14. S.J. Getting, and M. Perretti MC3-R as a novel target for antiinflammatory therapy Drug News Perspect 13 2000 19 27
15. S.J. Getting, R.J. Flower, L. Parente, R. de Medicis, A. Lussier, B.A. Woliztky, M.A. Martins, and M. Perretti Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins J. Pharmacol. Exp. Ther. 283 1997 123 130
16. S.J. Getting, R.J. Flower, and M. Perretti Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1 Br. J. Pharmacol. 120 1997 1075 1082
17. S.J. Getting, L. Gibbs, A.J. Clark, R.J. Flower, and M. Perretti POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation J. Immunol. 162 1999 7446 7453
18. S.J. Getting, H.C. Christian, C.W. Lam, F.N. Gavins, R.J. Flower, H.B. Schioth, and M. Perretti Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor J. Immunol. 170 2003 3323 3330
19. S.J. Getting, H.B. Schioth, and M. Perretti Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte- stimulating hormone peptides J. Pharmacol. Exp. Ther. 306 2003 631 637
20. S.J. Getting, C. Di Filippo, H.C. Christian, C.W. Lam, F. Rossi, M. D'Amico, and M. Perretti MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct J. Leukoc. Biol. 76 2004 845 853
21. A.B. Gutman, and T.F. Yu Effects of adrenocorticotropic hormone (ACTH) in gout Am. J. Med. 1950 24 30
22. P.S. Hench, C.H. Slocumb, H.F. Polley, and E.C. Kendal Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases J. Am. Med. Assoc. 144 1950 1327 1335
23. V.J. Hruby, S.D. Sharma, K. Toth, J.Y. Jaw, F. Al-Obeidi, T.K. Sawyer, and M.E. Hadley Design, synthesis, and conformation of superpotent and prolonged acting melanotropins Ann. N.Y. Acad. Sci. 680 1993 51 63
24. T. Ichiyama, H. Zhao, A. Catania, S. Furukawa, and J.M. Lipton α-melanocyte stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation Exp. Neurol. 157 1999 359 365
25. A. Kask, L. Rago, F. Mutulis, R. Pahkla, J.E. Wikberg, and H.B. Schioth Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats Biochem. Biophys. Res. Commun. 245 1998 90 93
26. C.W. Lam, and S.J. Getting Melanocortin receptor type 3 as a potential target for anti-inflammatory therapy Curr. Drug Targets Inflamm. Allergy 3 2004 311 315
27. C.W. Lam, S.J. Getting, and M. Perretti In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation J. Immunol. 174 2005 2297 2304
28. R. Latini, M. Bianchi, E. Correale, C.A. Dinarello, G. Fantuzzi, C. Fresco, A.P. Maggioni, M. Mengozzi, S. Romano, and L. Shapiro Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist J. Cardiovasc. Pharmacol. 23 1994 1 6
29. J.M. Lipton, and A. Catania Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH Immunol. Today 18 1997 140 145
30. N. Maulik, R.M. Engelman, Z. Wei, D. Lu, J.A. Rousou, and D.K. Das Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury Circulation 88 1993 II387 II394
31. J.V. Partanen, H. Soininen, and P.J. Riekkinen Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease? Electroencephalogr. Clin. Neurophysiol. 63 1986 547 551
32. K. Pentella, D.S. Bachman, and C.A. Sandman Trial of an ACTH4-9 Analogue (ORG 2766) in children with intractable seizures Neuropediatrics 13 1982 59 62
33. D.B. Richards, and J.M. Lipton Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit Peptides 5 1984 815 817
34. T.K. Sawyer, P.J. Sanfilippo, V.J. Hruby, M.H. Engel, C.B. Heward, J.B. Burnett, and M.E. Hadley 4-Norleucine, 7-d-phenylalanine-alpha-melanocyte- stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity Proc. Natl. Acad. Sci. U. S. A. 77 1980 5754 5758
35. T.E. Scholzen, C. Sunderkotter, D.H. Kalden, T. Brzoska, M. Fastrich, T. Fisbeck, C.A. Armstrong, J.C. Ansel, and T.A. Luger Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression Endocrinology 144 2003 360 370
36. 4-10 and desacetyl-alpha-MSH in humans Neuroendocrinology 70 1999 63 72
37. S. Taherzadeh, S. Sharma, V. Chhajlani, I. Gantz, N. Rajora, M.T. Demitri, I. Kelly, H. Zhao, T. Ichiyama, A. Catania, and J.M. Lipton α-MSH and its receptors in regulation of tumour necrosis factor-a production by human monocyte/macrophages Am. J. Physiol. 276 1999 R1289 R1294
38. M.B. Weinger, S.R. Chaplan, B.E. Girten, and F.L. Powell The respiratory effects of the cytokine regulating agent HP 228 alone and in combination with morphine in human volunteers Pharmacol. Biochem. Behav. 59 1998 759 766
39. H. Wessells, N. Levine, M.E. Hadley, R. Dorr, and V. Hruby Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II Int. J. Impot. Res. 12 Suppl 4 2000 S74 S79
40. J.E. Wikberg, R. Muceniece, I. Mandrika, P. Prusis, J. Lindblom, C. Post, and A. Skottner New aspects on the melanocortins and their receptors Pharmacol. Res. 42 2000 393 420